Interleukin-10 in patients with ST-segment elevation myocardial infarction

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages

  Falcao, Raquel Appa ^a,b   Christopher, Sanah ^a,b   Oddi, Claudia ^a,b   Reznikov, Leonid ^c   Grizzard, John D ^a,b   Abouzaki, Nayef A ^a,b   Varma, Amit ^a,b   Van Tassell, Benjamin W ^a,b   Dinarello, Charles A ^c   Abbate, Antonio ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Victoria Johnson Research Laboratories   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Interleukin; Myocardial infarction; Remodeling

Indexed keywords

GADOLINIUM; INTERLEUKIN 10; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; IL10 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CYTOKINE PRODUCTION; FEMALE; HEART ATRIUM REMODELING; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; HUMAN CELL; LETTER; LEUKOCYTE; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART VENTRICLE REMODELING; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANTIRHEUMATIC AGENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; VENTRICULAR REMODELING;

EID: 84894105654     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.126     Document Type: Article

References (11)

1. N.G. Frangogiannis The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities J Cardiovasc Pharmacol 2013 [Electronic publication ahead of print]
2. A.C. Fuchs, E.V. Granowitz, and L. Shapiro et al. Clinical, hematologic, and immunologic effects of interleukin-10 in humans J Clin Immunol 16 1996 291 303
3. K. Kaur, A.K. Sharma, and P.K. Singal Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction Am J Physiol Heart Circ Physiol 291 2006 H106 H113
4. G.B. Pott, E.D. Chan, C.A. Dinarello, and L. Shapiro Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood J Leukoc Biol 85 2009 886 895
5. A. Abbate, B.W. Van Tassell, and G. Biondi-Zoccai et al. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study] Am J Cardiol 111 2013 1394 1400
6. Z. Yang, B. Zingarelli, and C. Szabo Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury Circulation 101 2000 1019 1026
7. J.S. Burchfield, M. Iwasaki, and M. Koyanagi et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction Circ Res 103 2008 203 211
8. P. Krishnamurthy, M. Thal, and S. Verma et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium Circ Res 109 2011 1280 1289
9. C. Stumpf, K. Seybold, and S. Petzi et al. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction Eur J Heart Fail 10 2008 733 739
10. S. Schreiber, R.N. Fedorak, and O.H. Nielsen et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group Gastroenterology 119 2000 1461 1472
11. R.N. Fedorak, A. Gangl, and C.O. Elson et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group Gastroenterology 119 2000 1473 1482